Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > KRIT1(Gene name) > Human
  • Add your favorite
  • KRIT1 (Gene name),
  • Krev interaction trapped protein 1 (Protein name ),  KRIT1_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    KRIT1(CCM1);
    Protein name:
    Krev interaction trapped protein 1(Krev interaction trapped 1);
    Alternative:
    Cerebral cavernous malformations 1 protein;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Interacts with RAP1A. Interacts with CDH5.
    Function:
    Negative regulator of angiogenesis. Inhibits endothelial proliferation, apoptosis, migration, lumen formation and sprouting angiogenesis in primary endothelial cells. Promotes AKT phosphorylation in a NOTCH-dependent and independent manner, and inhibits EKR1/2 phosphorylation indirectly through activation of the DELTA-NOTCH cascade. Acts in concert with CDH5 to establish and maintain correct endothelial cell polarity and vascular lumen and these effects are mediated by recruitment and activation of the Par polarity complex and RAP1B. Required for the localization of phosphorylated PRKCZ, PARD3, TIAM1 and RAP1B to the cell junction. Plays an important role in the maintenance of the intracellular reactive oxygen species (ROS) homeostasis to prevent oxidative cellular damage. Regulates the homeostasis of intracellular ROS through an antioxidant pathway involving FOXO1 and SOD2. Facilitates the down-regulation of cyclin D1 levels required for cell transition from proliferative growth to quiescence by preventing the accumulation of intracellular ROS through the modulation of FOXO1 and SOD2 levels.
    Subcellular Location:
    Membrane Peripheral membrane protein Cell junction KRIT1 and CDH5 reciprocally regulate their localization to endothelial cell-cell junctions.
    Protein Attributes:
    Sequence length:
    736
    Sequence:
    50:
    MGNPENIEDA | YVAVIRPKNT | ASLNSREYRA | KSYEILLHEV | PIEGQKKKRK | 
    100:
    KVLLETKLQG | NSEITQGILD | YVVETTKPIS | PANQGIRGKR | VVLMKKFPLD | 
    150:
    GEKMGREASL | FIVPSVVKDN | TKYTYTPGCP | IFYCLQDIMR | VCSESSTHFA | 
    200:
    TLTARMLIAL | DKWLDERHAQ | SHFIPALFRP | SPLERIKTNV | INPAYATESG | 
    250:
    QTENSLHMGY | SALEIKSKML | ALEKADTCIY | NPLFGSDLQY | TNRVDKVVIN | 
    300:
    PYFGLGAPDY | SKIQIPKQEK | WQRSMSSVTE | DKERQWVDDF | PLHRSACEGD | 
    350:
    SELLSRLLSE | RFSVNQLDSD | HWAPIHYACW | YGKVEATRIL | LEKGKCNPNL | 
    400:
    LNGQLSSPLH | FAAGGGHAEI | VQILLNHPET | DRHITDQQGR | SPLNICEENK | 
    450:
    QNNWEEAAKL | LKEAINKPYE | KVRIYRMDGS | YRSVELKHGN | NTTVQQIMEG | 
    500:
    MRLSQETQQY | FTIWICSENL | SLQLKPYHKP | LQHVRDWPEI | LAELTNLDPQ | 
    550:
    RETPQLFLRR | DVRLPLEVEK | QIEDPLAILI | LFDEARYNLL | KGFYTAPDAK | 
    600:
    LITLASLLLQ | IVYGNYESKK | HKQGFLNEEN | LKSIVPVTKL | KSKAPHWTNR | 
    650:
    ILHEYKNLST | SEGVSKEMHH | LQRMFLQNCW | EIPTYGAAFF | TGQIFTKASP | 
    700:
    SNHKVIPVYV | GVNIKGLHLL | NMETKALLIS | LKYGCFMWQL | GDTDTCFQIH | 
    736:
    SMENKMSFIV | HTKQAGLVVK | LLMKLNGQLM | PTERNS
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    SMR:
    UniGene:
    KEGG:
    MIM:
    Pfam:
    Pfam:
    String:
    Uniprot:
     
    FOR
    ELISA Kit for Human Krev interaction trapped 1
    ELISA Kit for Human Krev interaction trapped 1
    ELISA Kit for Human Krev interaction trapped 1
    CLIA Kit for Human Krev interaction trapped 1
    CLIA Kit for Human Krev interaction trapped 1
    CLIA Kit for Human Krev interaction trapped 1
    Polyclonal Antibody for Human Krev interaction trapped 1
    Polyclonal Antibody for Human Krev interaction trapped 1
    Polyclonal Antibody for Human Krev interaction trapped 1
    Monoclonal Antibody for Human Krev interaction trapped 1
    Monoclonal Antibody for Human Krev interaction trapped 1
    Monoclonal Antibody for Human Krev interaction trapped 1
    Protein for Human Krev interaction trapped 1
    Protein for Human Krev interaction trapped 1
    Protein for Human Krev interaction trapped 1

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22."
      Serebriiskii I. , Estojak J. , Sonoda G. , Testa J.R. , Golemis E.A.
      Oncogene15:1043-1049(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA];NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2);TISSUE SPECIFICITY;INTERACTION WITH RAP1A
      tissue: Kidney.
      tissue: Mammary cancer.
    2. 2.
      "Cloning of the murine Krit1 cDNA reveals novel mammalian 5' coding exons."
      Zhang J. , Clatterbuck R.E. , Rigamonti D. , Dietz H.C.
      Genomics70:392-395(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)
    3. 3.
      "Computational and experimental analyses reveal previously undetected coding exons of the KRIT1 (CCM1) gene."
      Sahoo T. , Goenaga-Diaz E. , Serebriiskii I.G. , Thomas J.W. , Kotova E. , Cuellar J.G. , Peloquin J.M. , Golemis E. , Beitinjaneh F. , Green E.D. , Johnson E.W. , Marchuk D.A.
      Genomics71:123-126(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1);ALTERNATIVE SPLICING
    4. 4.
      "Mutation and expression analysis of the KRIT1 gene associated with cerebral cavernous malformations (CCM1)."
      Kehrer-Sawatzki H. , Wilda M. , Braun V.M. , Richter H.-P. , Hameister H.
      Acta Neuropathol.104:231-240(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1);ALTERNATIVE SPLICING;VARIANTS CCM1 SER-97 AND GLU-569
    5. 5.
      "Four novel and three known KRIT1 mutations in CCM Italian patients: Characterization at mRNA and protein level."
      Ferrera L. , Marini V. , Dorcaratto A. , Pigatto F. , Alberti F. , Forni M. , Cama A. , Viale G. , Origone P. , Mareni C. , Garre' C.
      Submitted (2003-09) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)
    6. 6.
      "Complete sequencing and characterization of 21,243 full-length human cDNAs."
      Ota T. , Suzuki Y. , Nishikawa T. , Otsuki T. , Sugiyama T. , Irie R. , Wakamatsu A. , Hayashi K. , Sato H. , Nagai K. , Kimura K. , Makita H. , Sekine M. , Obayashi M. , Nishi T. , Shibahara T. , Tanaka T. , Ishii S. , more...
      Nat. Genet.36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)
      tissue: Brain.
    7. 7.
      "The DNA sequence of human chromosome 7."
      Hillier L.W. , Fulton R.S. , Fulton L.A. , Graves T.A. , Pepin K.H. , Wagner-McPherson C. , Layman D. , Maas J. , Jaeger S. , Walker R. , Wylie K. , Sekhon M. , Becker M.C. , O'Laughlin M.D. , Schaller M.E. , Fewell G.A. , Delehaunty K.D. , Miner T.L. , more...
      Nature424:157-164(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    8. 8.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)
      tissue: Brain.
      tissue: Uterus.
    9. 9.
      "Identification of eight novel 5`-exons in cerebral capillary malformation gene-1 (CCM1) encoding KRIT1."
      Eerola I. , McIntyre B. , Vikkula M.
      Biochim. Biophys. Acta1517:464-467(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-243;ALTERNATIVE SPLICING
    10. 10.
      "Six novel and three known KRIT1 mutations in CCM patients: characterization at mRNA level."
      Marini V. , Ferrera L. , Dorcaratto A. , Forni M. , Capra V. , Origone P. , Mareni C. , Garre' C.
      Submitted (2005-03) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 244-281
    11. 11.
      "Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation."
      Zhang J. , Clatterbuck R.E. , Rigamonti D. , Chang D.D. , Dietz H.C.
      Hum. Mol. Genet.10:2953-2960(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;INTERACTION WITH ITGB1 AND ITGB1BP1;MUTAGENESIS OF ASN-192 AND TYR-195
    12. 12.
      "KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis."
      Zawistowski J.S. , Serebriiskii I.G. , Lee M.F. , Golemis E.A. , Marchuk D.A.
      Hum. Mol. Genet.11:389-396(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH ITGB1BP1;MUTAGENESIS OF ASN-192 AND TYR-195
    13. 13.
      "Krit 1 interactions with microtubules and membranes are regulated by Rap1 and integrin cytoplasmic domain associated protein-1."
      Beraud-Dufour S. , Gautier R. , Albiges-Rizo C. , Chardin P. , Faurobert E.
      FEBS J.274:5518-5532(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;IDENTIFICATION IN A COMPLEX WITH ITGB1BP1 AND RAP1A;INTERACTION WITH ITGB1BP1 AND RAP1A;SUBCELLULAR LOCATION;MUTAGENESIS OF 47-LYS--LYS-50 AND 192-ASN--TYR-195
    14. 14.
      "CCM1 regulates vascular-lumen organization by inducing endothelial polarity."
      Lampugnani M.G. , Orsenigo F. , Rudini N. , Maddaluno L. , Boulday G. , Chapon F. , Dejana E.
      J. Cell Sci.123:1073-1080(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;SUBCELLULAR LOCATION;INTERACTION WITH CDH5
    15. 15.
      "KRIT1 regulates the homeostasis of intracellular reactive oxygen species."
      Goitre L. , Balzac F. , Degani S. , Degan P. , Marchi S. , Pinton P. , Retta S.F.
      PLoS ONE5:E11786-E11786(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION
    16. 16.
      "Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling."
      Wuestehube J. , Bartol A. , Liebler S.S. , Bruetsch R. , Zhu Y. , Felbor U. , Sure U. , Augustin H.G. , Fischer A.
      Proc. Natl. Acad. Sci. U.S.A.107:12640-12645(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION
    17. 17.
      "A mechanism of Rap1-induced stabilization of endothelial cell--cell junctions."
      Liu J.J. , Stockton R.A. , Gingras A.R. , Ablooglu A.J. , Han J. , Bobkov A.A. , Ginsberg M.H.
      Mol. Biol. Cell22:2509-2519(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;SUBCELLULAR LOCATION;INTERACTION WITH RAP1A;MUTAGENESIS OF ARG-452
    18. 18.
      "Structural basis for small G protein effector interaction of Ras-related protein 1 (Rap1) and adaptor protein Krev interaction trapped 1 (KRIT1)."
      Li X. , Zhang R. , Draheim K.M. , Liu W. , Calderwood D.A. , Boggon T.J.
      J. Biol. Chem.287:22317-22327(2012) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 420-736 IN COMPLEX WITH RAP1B;MUTAGENESIS OF SER-430; ARG-432 AND ARG-452;INTERACTION WITH RAP1B
    19. 19.
      "Structural basis of the junctional anchorage of the cerebral cavernous malformations complex."
      Gingras A.R. , Liu J.J. , Ginsberg M.H.
      J. Cell Biol.199:39-48(2012) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.49 ANGSTROMS) OF 417-736 IN COMPLEX WITH HEG1;INTERACTION WITH HEG1; RAP1A AND CCM2;SUBCELLULAR LOCATION;MUTAGENESIS OF LEU-717 AND LEU-721
    20. 20.
      "Mechanism for KRIT1 release of ICAP1-mediated suppression of integrin activation."
      Liu W. , Draheim K.M. , Zhang R. , Calderwood D.A. , Boggon T.J.
      Mol. Cell0:0-0(2013)
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.54 ANGSTROMS) OF 1-198 IN COMPLEX WITH ITGB1BP1;INTERACTION WITH ITGB1BP1;FUNCTION;DOMAIN;MUTAGENESIS OF ALA-176; ARG-179; PRO-182; ARG-185; ASN-192 AND TYR-195
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Alpha Tumor necrosis Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter